NCR3 and neoplasm: In GIST, NK cells express decreased levels of their specific activatory receptor NKp30/NCR3 both inside the tumor and at the periphery compared to circulating NKp30+ NK cells of healthy donors, despite the similarity of NK cell blood counts in both groups [82].